In PKT mice, flow cytometric analysis of tumor-infiltrating effector memory CD4+ T cells using lineage-specific markers revealed no significant difference in the frequency of immunosuppressive Treg (CD4+CD62L−CD44+Foxp3high) population among the treatment cohorts (Fig. 5I). This evidence concerns the gene CD4 and neoplasm.